Shyndec Pharma Gets China Pharmaceutical Ingredient Approval for Anaesthesia Supplementary Drug

MT NewswiresJan 8 00:28 ET

Shanghai Shyndec Pharmaceutical Co., Ltd.'s (SHSE:600420) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Simply Wall StJan 6 20:21 ET

Chinese Drug Regulator Denies Marketing of Shyndec Pharmaceutical's UTI Treatment Drug

MT NewswiresJan 3 03:35 ET

Shyndec Pharmaceutical Unit Gets Nod to Register Cefpodoxime Proxetil Tablets

MT NewswiresDec 12, 2024 00:43 ET

Shyndec Pharma Unit's Codeine Phosphate Included in China's Listing of Chemical Raw Materials

MT NewswiresDec 5, 2024 22:54 ET

Shanghai Shyndec Pharmaceutical's (SHSE:600420) Five-year Total Shareholder Returns Outpace the Underlying Earnings Growth

Simply Wall StNov 27, 2024 17:36 ET